Results 61 to 70 of about 10,275,652 (198)

BS1211 COOP BANK STAGE II SUPP

, 2016
BS1211 COOP BANK STAGE II ...
Murang'a University of Technology
core  

Economic Burden of Treatment-Resistant Depression

Journal of Pharmacoeconomics and Pharmaceutical Management
Background: Treatment-resistant depression (TRD) is a highly prevalent condition and is generally referred to as the failure of at least two or more prior treatments with antidepressants or augmentation therapy with adequate dose and duration.
Swati Sucharita Dash, Merlin Roshma Sherin, Jignesh Bhate, Guruprasad KS Rao   +3 more
doaj  

Rerum Boicarum libri quinque una cum libro sexto hactenus inedito, historiam a gentis origine ad annum DCCCXLIV. complexi

Die Vorlage enthält insgesamt 4 WerkeNicht identisch mit VD18 14771357, dort ohne Buchbinderanweisung auf dem letzten BlattVorlageform des Erscheinungsvermerks: Avgvstae Vindelic. Impensis Conradi Henrici Stage. MDCCLXXVII.Titelkupfer, 2 Ill. (Kupferst.
Welser, Marcus
core   +1 more source

Stage II [PDF]

, 2020
openaire   +2 more sources

Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.

, 2018
The aim of this study was to examine temporal trends in overall and stage-specific incidence of melanoma. Using population-based data on patients diagnosed with melanoma in East Anglia, England, 1996-2015, we estimated age-standardized time trends in ...
DC Greenberg (21892172), A Herbert (10048895), ME Barclay (21856331), GA Abel (7681217), G Lyratzopoulos (9237197), MM Koo (21892187), NJ Levell (21892190)   +6 more
core   +4 more sources

Optimizing Treatment Pathways With Multidisciplinary Team Discussions in Stage II to III NSCLC

JTO Clinical and Research Reports
Stage II to III NSCLC management is an evolving field with several multimodal treatment strategies. Management decisions are dictated by disease stage, resectability, biomarker testing, and resource availability, along with patient factors and ...
Neel P. Chudgar, MD, Deepti Behl, MD, Kristin Higgins, MD, Boris Sepesi, MD, Lynette Sholl, MD, Lonny Yarmus, DO, Jessica Donington, MD, MSCR   +6 more
doaj   +1 more source

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer

Frontiers in Oncology
Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively.
Eva Budinská, Martina Čarnogurská, Tina Catela Ivković, Táňa Macháčková, Táňa Macháčková, Marie Boudná, Marie Boudná, Lucie Pifková, Lucie Pifková, Ondřej Slabý, Ondřej Slabý, Beatrix Bencsiková, Vlad Popovici   +12 more
doaj   +1 more source

Hindfoot Alignment in Stage II Adult Acquired Flatfoot Deformity

Foot & Ankle Orthopaedics, 2018
Category: Hindfoot Introduction/Purpose: Previous work has demonstrated that the amount of radiographic hindfoot correction required at the time of adult acquired flatfoot deformity (AAFD) surgical treatment can be predicted by the amount of radiographic
Cesar de Cesar Netto MD, PhD, Lauren Roberts MD, Grace Kunas BA, Anca Marinescu BA, Dylan Soukup BSc, Scott Ellis MD   +5 more
doaj   +1 more source

What inference for two-stage phase II trials?

BMC Medical Research Methodology, 2012
Background Simon’s two-stage designs are widely used for cancer phase II trials. These methods rely on statistical testing and thus allow controlling the type I and II error rates, while accounting for the interim analysis.
Porcher Raphaël, Desseaux Kristell
doaj   +1 more source

A mid-term follow-up of Koutsogiannis’ osteotomy in adult-acquired flatfoot stage II and “early stage III”

SICOT-J, 2017
Introduction: Koutsogiannis’ osteotomy has been widely described to treat adult-acquired flatfoot. However, few articles describe its midterm follow-up.
Arvinius Camilla, Manrique Elena, Urda Antonio, Cardoso Zulema, Galeote Jose Enrique, Marco Fernando   +5 more
doaj   +1 more source